← Back to Search
The Seventh Report Of The Joint National Committee On Prevention, Detection, Evaluation, And Treatment Of High Blood Pressure: The JNC 7 Report.
A. Chobanian, G. Bakris, H. Black, W. Cushman, L. Green, J. Izzo, Daniel W. Jones, B. Materson, S. Oparil, Jackson T Wright, E. Roccella
Published 2003 · Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure" provides a new guideline for hypertension prevention and management. The following are the key messages(1) In persons older than 50 years, systolic blood pressure (BP) of more than 140 mm Hg is a much more important cardiovascular disease (CVD) risk factor than diastolic BP; (2) The risk of CVD, beginning at 115/75 mm Hg, doubles with each increment of 20/10 mm Hg; individuals who are normotensive at 55 years of age have a 90% lifetime risk for developing hypertension; (3) Individuals with a systolic BP of 120 to 139 mm Hg or a diastolic BP of 80 to 89 mm Hg should be considered as prehypertensive and require health-promoting lifestyle modifications to prevent CVD; (4) Thiazide-type diuretics should be used in drug treatment for most patients with uncomplicated hypertension, either alone or combined with drugs from other classes. Certain high-risk conditions are compelling indications for the initial use of other antihypertensive drug classes (angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, β-blockers, calcium channel blockers); (5) Most patients with hypertension will require 2 or more antihypertensive medications to achieve goal BP (<140/90 mm Hg, or <130/80 mm Hg for patients with diabetes or chronic kidney disease); (6) If BP is more than 20/10 mm Hg above goal BP, consideration should be given to initiating therapy with 2 agents, 1 of which usually should be a thiazide-type diuretic; and (7) The most effective therapy prescribed by the most careful clinician will control hypertension only if patients are motivated. Motivation improves when patients have positive experiences with and trust in the clinician. Empathy builds trust and is a potent motivator. Finally, in presenting these guidelines, the committee recognizes that the responsible physician's judgment remains paramount.
This paper references
National High Blood Pressure Education Program.
C. Lenfant (1986)
Physicians Desk Reference
E. Barnhart (1990)
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.
S. Yusuf (1991)
Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators
G. Murray (1993)
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.
E. Lewis (1993)
A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.
L. Køber (1995)
Recommendations for the use of home (self) and ambulatory blood pressure monitoring. American Society of Hypertension Ad Hoc Panel.
T. Pickering (1996)
Compliance enhancement. A call for multidisciplinary team approaches.
M. Hill (1996)
The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI)
Obesity Evaluation and Treatment: Expert Committee Recommendations
S. Barlow (1998)
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
M. R. Stearne (1998)
Absence of a deleterious effect of calcium channel blockers in patients with left ventricular dysfunction after myocardial infarction: The SAVE Study Experience. SAVE Investigators. Survival and Ventricular Enlargement.
W. D. Hager (1998)
Reflections on the sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure
S. Sheps (1999)
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.
S. Yusuf (2000)
Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension.
J. He (2000)
Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification.
L. Ogden (2000)
National Heart, Lung, and Blood Institute Workshop on Sodium and Blood Pressure : a critical review of current scientific evidence.
A. Chobanian (2000)
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
B. Pitt (2000)
Improving preventive care by prompting physicians.
E. Balas (2000)
Progressive resistance exercise and resting blood pressure : A meta-analysis of randomized controlled trials.
G. Kelley (2000)
Prognostic value of ambulatory blood pressure : current evidence and clinical implications.
P. Verdecchia (2000)
Clinical Advisory Statement. Importance of systolic blood pressure in older Americans.
J. Izzo (2000)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.
E J Lewis (2001)
Effect of carvedilol on survival in severe chronic heart failure.
M. Packer (2001)
Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.
H. Dargie (2001)
Characteristics of patients with uncontrolled hypertension in the United States.
D. Hyman (2001)
Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial.
M. Di Bari (2001)
Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial
H. Black (2001)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.
B. Brenner (2001)
Effects of Alcohol Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials
Xue Xin (2001)
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
J. Cohn (2001)
An evidence-based review of patient-centered behavioral interventions for hypertension.
L. Boulware (2001)
Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack
S. MacMahon (2001)
Effects of ACE Inhibitors, Calcium Antagonists, and Other Blood Pressure lowering Drugs
R. Thakkar (2001)
Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet
F. Sacks (2001)
Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study
R. Vasan (2001)
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients
E. Braunwald (2002)
ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary.
S. Hunt (2002)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
J. Rossouw (2002)
National Ambulatory Medical Care Survey: 2000 summary.
D. Cherry (2002)
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
B. Dahlöf (2002)
Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program.
P. Whelton (2002)
Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy.
S. Kjeldsen (2002)
National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
S. Grundy (2002)
Effect of Aerobic Exercise on Blood Pressure
Seamus P Whelton (2002)
Prevalence and trends in obesity among US adults, 1999-2000.
K. Flegal (2002)
Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study.
R. S. Vasan (2002)
Successful blood pressure control in the African American Study of Kidney Disease and Hypertension.
J. Wright (2002)
Original Papers. Success and Predictors of Blood Pressure Control in Diverse North American Settings: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
W. Cushman (2002)
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
C. Baigent (2002)
A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.
L. Wing (2003)
Age-specific relevance of usual blood pressure to vascular mortality
S. Lewington (2003)
Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
H. Black (2003)
Two words to improve physician-patient communication: what else?
P. A. Barrier (2003)
Treatment of hypertension in adults with diabetes.
C. Arauz-Pacheco (2003)
Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
B. Pitt (2003)
Health outcomes associated with various antihypertensive therapies used as first-line agents
B. Psaty (2003)
This paper is referenced by
Skin diseases in the Da Qing Diabetes Study: a cross-sectional study
Changbing Shen (2021)
Reply to the Letter to the Editor on: "Effectiveness of Multi-activity, High-intensity Interval Training in School-aged Children."
S. Ketelhut (2021)
Prevalence, clinical profile, and stroke risk of atrial fibrillation in rural Andhra Pradesh, India (The AP-AF study) – Rationale and design
D. Saggu (2021)
Aortic enlargement in chronic obstructive pulmonary disease (COPD) and emphysema: The multi-ethnic study of atherosclerosis (MESA) COPD study.
K. Fujikura (2021)
Long-term blood pressure outcomes of laparoscopic adrenalectomy in trHTN patients
Yue Deng (2021)
Mediating effects of insulin resistance on the development of hypertension associated with elevated serum uric acid: a prospective cohort study
Ruonan Wang (2021)
Lifestyle Interventions Reduce the Need for Guideline-Directed Antihypertensive Medication.
A. Hinderliter (2021)
Association between body mass index and blood pressure levels across socio-demographic groups and geographical settings: analysis of pooled data in Peru
A. Bernabé-Ortiz (2021)
Change in Urine Albumin-to-Creatinine Ratio and Risk of Diabetic Peripheral Neuropathy in Type 2 Diabetes: A Retrospective Cohort Study
M. Zhong (2021)
Evaluating Factors Associated With Blood Pressure Control in the Early Post–Kidney Transplant Period
Matthew A. Zuziela (2021)
Blood pressure reduction and anti‐hypertensive treatment choice: A post‐hoc analysis of the SPRINT trial
J. Ferreira (2021)
The Effect of Acupressure on Blood Pressure Level and Pulse Rate in Individuals With Essential Hypertension
S. Biçer (2021)
Risk factors for hypertensive crisis in adult patients: a systematic review
Irina Benenson (2021)
Vascular Consequences of Obstructive Sleep Apnea
E. Schwarz (2021)
Another approach on elaborating frequency tables using GAUSS´s normal distribution theory
Samuel Carlos Victorino (2021)
BIOMEDICAL STUDY ON HOSPITAL ANXIETY AND ECONOMICAL STRESS IN NORMOTENSIVE AND HYPERTENSIVE DIABETIC II PATIENTS
Khim-dhoj Karki (2021)
Combination of low ankle-brachial index and high ankle-brachial index difference for mortality prediction
Wei-Chung Tsai (2021)
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SPH3127: A Phase I, Randomized, Double-Blind, Placebo-Controlled Trial.
Shan Jing (2021)
The Association Between Male Infertility and Cardiometabolic Disturbances: A Population-Based Study
S. Behboudi-Gandevani (2021)
Brainstem network connectivity with mid-anterior insula predicts lower systolic blood pressure at rest in older adults with hypertension
R. McIntosh (2021)
Association of long-term exposure to ambient particulate pollution with stage 1 hypertension defined by the 2017 ACC/AHA Hypertension Guideline and cardiovascular disease: The CHCN-BTH cohort study.
H. Cao (2021)
Relationships between obstructive sleep apnea syndrome and cardiovascular risk factors
L. Evlampieva (2021)
Dietary choline and betaine intake and risk of hypertension development: a 7.4-year follow-up.
M. Golzarand (2021)
Association of waist-to-height ratio with hypertension and its subtypes in southern China
Peng Lu (2021)
The Prevalence of Metabolic Disease Multimorbidity and Its Associations With Spending and Health Outcomes in Middle-Aged and Elderly Chinese Adults
Yang Zhao (2021)
Chlorthalidone versus hydrochlorothiazide: major cardiovascular events, blood pressure, left ventricular mass, and adverse effects.
G. Roush (2021)
Anthropometric, socio-demographic and biochemical risk factors of hypertension in Lagos, Nigeria
Charity E. Chukwu (2021)
Long-term body mass trajectories and hypertension by sex among Chinese adults: a 24-year open cohort study
Ruru Liu (2021)
The effect of vascular health factors on white matter microstructure mediates age-related differences in executive function performance
D. Hoagey (2021)
Maternal Blood Pressure in Relation to Prenatal Lipid-Based Nutrient Supplementation and Adverse Birth Outcomes in a Ghanaian Cohort: A Randomized Controlled Trial and Cohort Analysis
Alyssa M Abreu (2021)
Risk of Incident Hypertension According to Physical Activity and Temporal Changes in Weight.
J. Kang (2021)
Cardiovascular disease risk, awareness, and treatment in people with epilepsy
Samuel W Terman (2021)See more